First line chemotherapy with sequential administration of gemcitabine followed by docetaxel in elderly advanced non-small-cell lung cancer (NSCLC) patients: A multicenter phase II study

被引：0
|
作者：
Lo Dico, M. [1 ]
Vasile, E. [1 ]
Tibaldi, C. [1 ]
Antonuzzo, A. [2 ]
Di Marsico, R. [3 ]
Tartarelli, G. [4 ]
Fabbri, A. [5 ]
Mazzoni, E.
Andreuccetti, M.
D'Alessandro, M. [6 ]
Nacci, A. [7 ]
Falcone, A. [8 ]
机构：
[1] Civil Hosp, Div Med Oncol, Livorno, Italy
[2] Civil Hosp, Div Med Oncol, Piombino, Italy
[3] Civil Hosp, Div Med Oncol, Cencina, Italy
[4] Civil Hosp, Div Med Oncol, Viareggio, Italy
[5] Civil Hosp, Div Pneumol, Pistola, Italy
[6] Civil Hosp, Div Med Oncol, Empoli, Italy
[7] Santa Chiara Hosp, Div Med Oncol, Pisa, Italy
[8] Univ Pisa, ITT, Tumori, Italy
来源：
ANNALS OF ONCOLOGY | 2007年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：35 / 35
页数：1
相关论文
共 50 条
  • [41] Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy
    Chen, YM
    Perng, RP
    Lin, WC
    Wu, HW
    Tsai, CM
    Whang-Peng, J
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2002, 25 (05): : 509 - 512
  • [42] A phase II multicenter study of combined topotecan and gemcitabine as first line chemotherapy for advanced non-small cell lung cancer
    Joppert, MG
    Garfield, DH
    Gregurich, MA
    Nemunaitis, JJ
    Marsland, TA
    Khandelwal, P
    Asmar, L
    [J]. LUNG CANCER, 2003, 39 (02) : 215 - 219
  • [43] Third-line chemotherapy with gemcitabine or docetaxel in patients with advanced non-small cell lung cancer (NSCLC).
    Morgensztern, D
    Lim, WT
    Subramanian, J
    Viswanathan, A
    Govindan, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 694S - 694S
  • [44] Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer:: a lung cancer Galician group phase II study
    Casal, Joaquin
    Amenedo, Margarita
    Mel, Jose Ramon
    Anton, Luis Miguel
    Rodriguez-Lopez, Ruben
    Lopez-Lopez, Rafael
    Gonzalez-Ageitos, Ana
    Castellanos, Javier
    Constenla, Manuel
    Tisaire, Jose L.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (05) : 725 - 732
  • [45] Gemcitabine plus docetaxel as first-line chemotherapy in patients with advanced non-small cell lung cancer: a lung cancer Galician group phase II study
    Joaquín Casal
    Margarita Amenedo
    José Ramón Mel
    Luis Miguel Antón
    Rubén Rodríguez-López
    Rafael López-López
    Ana González-Ageitos
    Javier Castellanos
    Manuel Constenla
    José L. Tisaire
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 60 : 725 - 732
  • [46] Phase II Study of Cetuximab, Docetaxel, and Gemcitabine in Patients With Previously Untreated Advanced Non-Small-Cell Lung Cancer
    Spigel, David R.
    Greco, F. Anthony
    Thompson, Dana S.
    Webb, Charles
    Rubinsak, James
    Inhorn, Roger C.
    Reeves, James, Jr.
    Vazquez, Elizabeth R.
    Lane, Cassie M.
    Burris, Howard A., III
    Hainsworth, John D.
    [J]. CLINICAL LUNG CANCER, 2010, 11 (03) : 198 - 203
  • [47] Phase II study of Docetaxel and Cisplatin in a circadian timing as first line chemotherapy (CT) in advanced non small cell lung cancer (NSCLC)
    Faderl, B
    von Pawel, J
    Wagner, H
    Krauss, C
    Achterrath, W
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S256 - S256
  • [48] Phase II study of docetaxel and cisplatin in a circadian timing as first line chemotherapy (CT) in advanced non small cell lung cancer (NSCLC)
    Faderl, B
    von Pawel, J
    Wagner, H
    Krauss, C
    Achterrath, W
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 89 - 89
  • [49] Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small-cell lung cancer (NSCLC): SAKK protocol 19/03
    D'Addario, G.
    Rauch, D.
    Stupp, R.
    Pless, M.
    Stahel, R.
    Mach, N.
    Jost, L.
    Widmer, L.
    Tapia, C.
    Bihl, M.
    Mayer, M.
    Ribi, K.
    Lerch, S.
    Bubendorf, L.
    Betticher, D. C.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 (04) : 739 - 745
  • [50] Multicenter phase II study of the combination of cartioplatin and paclitaxel as first line treatment in elderly patients with advanced non small cell lung cancer (NSCLC).
    Okamoto, I
    Moriyama, E
    Kishi, H
    Nomura, M
    Imamura, F
    Iwagoe, H
    Miyajima, S
    Mori, T
    Setoguchi, K
    Matsumoto, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 675S - 675S
12345